Panacea Life Sciences Holdings, Inc.
PLSH
$0.0539
$0.005912.29%
| 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -1.45M | -2.21M | -2.15M | -1.86M | -1.79M |
| Total Depreciation and Amortization | 383.50K | 443.60K | 424.00K | 422.70K | 422.60K |
| Total Amortization of Deferred Charges | -- | 0.00 | 0.00 | 0.00 | 38.30K |
| Total Other Non-Cash Items | 5.40K | 602.10K | 382.00K | 539.70K | 182.30K |
| Change in Net Operating Assets | 700.10K | 1.16M | 616.20K | 418.50K | 834.30K |
| Cash from Operations | -357.10K | 1.60K | -728.90K | -483.30K | -313.90K |
| Capital Expenditure | -5.00K | -17.90K | -22.80K | -9.40K | -15.20K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -5.00K | -17.90K | -22.80K | -9.40K | -15.20K |
| Total Debt Issued | 448.60K | 229.60K | 785.20K | 480.60K | 595.40K |
| Total Debt Repaid | -79.80K | -113.90K | -40.20K | -53.00K | -200.00K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 368.80K | 115.80K | 745.00K | 427.60K | 395.40K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 6.70K | 99.40K | -6.70K | -65.00K | 66.30K |
